Phase I trial of cannabidiol and another cannabinoid, GWP 42002, for glioma.
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2014
At a glance
- Drugs Cannabinoids (Primary)
- Indications Glioma
- Focus Adverse reactions
- 13 Jun 2014 Status changed from planning to recruiting as per the GW Pharmaceuticals media release.
- 01 Oct 2012 New trial record